CRN on omega-3s
This article was originally published in The Tan Sheet
Executive Summary
A white paper on the "the importance of Omega-3 fatty acids for heart health" notes that following review by FDA and the American Heart Association, "when it comes to omega-3s and heart health, the evidence is strongest for EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid)," the Council for Responsible Nutrition states. The paper was released July 20 by CRN's Omega-3 Working Group. "It is important to educate various audiences on the benefits obtained from the different types of omega-3 fatty acids," according to Ian Newton, executive director of the working group. The paper "helps clarify some of the differences." FDA approved a qualified health claim for EPA and DHA in September (1"The Tan Sheet" Sept. 13, 2004, p. 12)...
You may also be interested in...
Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.